The management of synchronous prostate and rectal cancer is a challeging task for the general surgeons and urologists, due to the complex anatomy of the pelvis and the sequential significant effects on the patient's functional independency and quality of life.
As both rectal and prostate cancers still remain leading causes of death in the male population, along with the increase of the average life expectancy, it is certain that synchronous prostate and rectal cancer will be a clinical scenario that the clinicians of the future will encounter more frequently. Our aim is to perform a comprehensive review on the management of this oncological entity, focusing on the significance of multidisciplinary approach which will enable the formation of an accurate strategy plan, having at all times the patient in the center of desicion-making.
Written by:
Seretis C, Seretis F, Liakos N. Are you the author?
Department of Colorectal Surgery, Good Hope Hospital, Heart of England NHS Foundation Trust, Birmingham, UK; Department of General Surgery, Medical School, University of Patras, Greece; Department of Urology, St. Katharinen-Hospital GmbH, Frechen, Germany.
Reference: J Clin Med Res. 2014 Jun;6(3):157-161.
doi: 10.14740/jocmr1796w
PubMed Abstract
PMID: 24734141
UroToday.com Prostate Cancer Section
